Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
- PMID: 2065763
- DOI: 10.1007/BF01949891
Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
Abstract
The effects of VIP (300 pmol/kg), injected via the portal vein, on the glycogen content of the liver and on glycemia, were studied in the rat in vivo. VIP enhanced glycogenolysis and caused hyperglycemia in a time-dependent manner.